scholarly journals Treating with insulin pumps in children under the age of 10 years from diabetes type 1 diagnosis – 3 years follow-up

2018 ◽  
Vol 17 (2) ◽  
pp. 81-88
Author(s):  
Katarzyna Piechowiak ◽  
◽  
Ewelina Politowska ◽  
Paweł Politowski ◽  
Agnieszka Szypowska ◽  
...  
Keyword(s):  
Diabetes Type ◽  
Diabetes Type 1 ◽  
Insulin Pumps

P612: Small and large fibre neuropathy in patients with diabetes type 1 compared with type 2: a follow-up study

2014 ◽  
Vol 125 ◽  
pp. S215
Author(s):  
S. Løseth ◽  
E. Stålberg ◽  
S. Lindal ◽  
R. Jorde ◽  
S.I. Mellgren
Keyword(s):  
Diabetes Type ◽  
Diabetes Type 1 ◽  
Follow Up Study ◽  
Patients With Diabetes ◽  
Large Fibre

scholarly journals Glicemic control in prepubertal and pubertal patients with diabetes type 1 - a one year ambulatory follow-up

2001 ◽  
Vol 77 (1) ◽  
pp. 41-4
Author(s):  
Marília B. Gomes ◽  
Simone H. Castro ◽  
Tatiana Garfinkel ◽  
Luis Maurício P. Fernandes ◽  
Edna F. Cunha ◽  
...  
Keyword(s):  
Diabetes Type ◽  
Diabetes Type 1 ◽  
Patients With Diabetes ◽  
One Year

scholarly journals Mothers’ Experiences of Maze Path of Type 1 Diabetes Diagnosis in Children

1970 ◽  
Vol 28 (5) ◽  
Author(s):  
Maryam Khandan ◽  
Batool Tirgari ◽  
Farokh Abazari ◽  
Mohammad Ali Cheraghi
Keyword(s):  
Type 1 Diabetes ◽  
Health Professionals ◽  
Qualitative Interviews ◽  
Diabetes Type ◽  
Diabetes Diagnosis ◽  
Diabetes Type 1 ◽  
Medical File ◽  
One Year

BACKGROUND: Incidence of diabetes Type 1 in children with non-classic symptoms is one of the reasons for the delay in their follow-up. Failure in its diagnosis by the health professional exposes the mothers tomany challenges. This study was conducted to exploremothers’ experiences in the diagnosis pathway of diabetes Type 1 in children.METHODS: Semi-structured qualitative interviews were conducted with fifteen mothers of children with Type 1 diabetes.theywere selected by the purposefull sampling method.Their child had a medical file in diabetes centers in Kerman, Iran, at least one year has passed of diabetes diagnosis in their child and the maximum age of the child is 14 years. Data were analyzed using content analysis.Three themes and nine sub-themes emerged during dataanalysis.RESULTS: The extracted themes included “presence in the maze path to the child's disease”, “facing the reality of the child's disease”, and “to grin and bear with new conditions”.CONCLUSIONS: According to the finding, these mothers experienced various challenges. Therefore, identification of thesechallenges by health professionals to prevent and decrease of Them, is necessary. 

scholarly journals The Automatic Regulation of the Basal Dose on the Insulin Pump for the Treatment of Patients that have Diabetes Type 1

2010 ◽  
Vol 10 (2) ◽  
pp. 100-106 ◽  
Author(s):  
Sifet Mehanović ◽  
Midhat Mujić
Keyword(s):  
Glucose Sensor ◽  
Insulin Pump ◽  
Artificial Pancreas ◽  
Life Quality ◽  
Diabetes Type ◽  
Early Years ◽  
Automatic Regulation ◽  
Diabetes Type 1 ◽  
Insulin Pumps

Diabetes mellitus type 1 is a chronic metabolic disorder, and its main characteristic is Hyperglycemia. It usually occurs in the early years because of the absolute or relative absence of the active insulin that is caused by the autoimmune disease of the β cells of the pancreas. Despite the numerous researches and efforts of the scientists, the therapy for Diabetes type 1 is based on the substitution of insulin. Even though the principles of the therapy have not changed so much, still some important changes have occurred in the production and usage of insulin. Lately, the insulin pumps are more frequent in the therapy for Diabetes type 1. The functioning of the pump is based on the continuing delivery of insulin in a small dose (“the basal dose”), that keeps the level of glycemia in the blood constant. The increase of glycemia during the meal is reduced with the additional dose of insulin (“the bolus dose”). The use of the insulin pumps and the continuing glucose sensors has provided an easier and more efficient monitoring of the diabetes, a better metabolic control and a better life quality for the patient and his/her family.This work presents the way of automatic regulation of the basal dose of insulin through the synthesis of the functions of the insulin pump and the continuing glucose sensor. The aim is to give a contribution to the development of the controlling algorithm on the insulin pump for the automatic regulation of the glucose concentration in the blood. This could be a step further which is closer to the delivery of the dose of insulin that is really needed for the basic needs of the organism, and a significant contribution is given to the development of the artificial pancreas.

Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1

2019 ◽  
Author(s):  
Guido Kramer ◽  
Laura Michalak ◽  
Ulrich Alfons Müller ◽  
Christof Kloos ◽  
Christoph Werner ◽  
...  
Keyword(s):  
Metabolic Control ◽  
Treatment Satisfaction ◽  
Glucose Monitoring ◽  
Diabetes Type ◽  
Diabetes Type 1 ◽  
Baseline Hba1c ◽  
Flash Glucose Monitoring ◽  
Interstitial Glucose

Abstract Objective The aim of this study was to follow-up people with diabetes type 1 and Flash Glucose Monitoring (FGM) regarding metabolic control and treatment satisfaction. Methods 40 people with diabetes type 1 and FGM use of ≥6 months were included in the study (female 55%, age 50.9 y, diabetes duration 21.9 y, HbA1c 7.4%, 57.6 mmol/mol, insulin pump therapy 32.5%). The number of scans per day and time/frequency of hypoglycaemia (interstitial glucose value ≤3.9 mmol/l) was recorded from 28 days of the glucose readings. Change of treatment satisfaction was assessed with the DTSQc questionnaire at follow-up (range−18 to+18). Results Mean time of follow-up was 1.0±0.4 y. At follow-up, all participants scanned interstitial glucose 11.9±7.7 times/day. Number of self-monitoring of blood glucose decreased from 6.7±4.2 (baseline) to 0.9±1.8 (follow-up) per day (p<0.001). In individuals with baseline HbA1c ≤7.5%, HbA1c increased (from 6.6±0.7% to 7.0±0.4%, p=0.020). On the contrary, in people with HbA1c>7.5%, HbA1c decreased (from 8.2±0.7% to 7.8±0.7%, p=0.001). In all participants, there were no differences regarding insulin dosage (33.8±12.9 vs. 34.6±13.9 IU/day, p=0.679) and number of insulin injections/day (3.9±2.3 vs. 4.0±2.6, p=0.813) between baseline and follow-up. Frequency of symptomatic hypoglycaemia was at baseline 0.3±0.3 events/day and 0.48±0.36 events/day (recognised, symptomatic events) at follow-up, respectively. In addition, 0.26±0.21 unrecognised hypoglycaemic events/day occurred at follow-up. Treatment satisfaction increased by+12.6 points. Conclusions FGM was associated with an enormous increase in treatment satisfaction and slightly improved metabolic control in people with baseline HbA1c>7.5%. The number of capillary glucose measurements decreased significantly.

Pediatric Self-Efficacy for Diabetes-Type-1 Scale--German Version

2020 ◽  
Author(s):  
Dominik Sethe ◽  
Arndt Büssing ◽  
Dörte Hilgard ◽  
Bettina Berger
Keyword(s):  
Self Efficacy ◽  
Diabetes Type ◽  
Diabetes Type 1 ◽  
German Version
Sign in / Sign up

Export Citation Format

Share Document